DS147 improves pregnancy in mice with embryo implantation dysfunction induced by controlled ovarian stimulation

Abstract

The study examined the effect of DS147, the bioactive component of the traditional herbal recipe Bangdeyun, on pregnancy in mice with embryo implantation dysfunction induced by controlled ovarian stimulation (COS), and the underlying mechanisms. Female mice were superovulated by intraperitoneal injection of 7.5 IU of pregnant mare serum gonadotropin (PMSG) followed by an additional injection of 7.5 IU hCG 48 h later to establish embryo implantation dysfunction (EID) model. Pregnant mice were randomly divided into normal control group, COS group and DS147-treated groups. The pregnancy rate and the average implantation site were obtained on pregnancy day 8 (PD8). The side effect of 200 mg/kg of DS147 on naturally pregnant mice was also observed. Further, the uterine and ovarian tissue samples were collected on PD5 for measuring their weights, observing the development of the endometrium and ovary, and detecting the endometrial expression of MMP-2, TIMP-2, CD34 and angiogenin (ANG). The female mice treated with DS147 at doses of 100 to 800 mg/kg showed a higher pregnancy rate than those in COS group, and the highest pregnancy rate of 83.3% occurred in the 200 mg/kg DS147-treated group. Moreover, no obvious side effect was found in mice treated with 200 mg/kg DS147 on PD8 and PD16. The ovarian and uterine weights, and the expression levels of MMP-2, ANG and CD34 were significantly increased in DS147-treated groups when compared with COS group. The TIMP-2 expression level was much lower in DS147-treated mice than in COS mice and the ratio of MMP-2/TIMP-2 was much higher in DS147-treated group than in COS group, and even higher than normal control group. In all, these findings suggest that DS147 may improve pregnancy in mice with COS-induced EID by promoting matrix degradation and angiogenesis, and improving the development of corpus luteum and endometrial decidualization around the implantation window.

Keywords

DS147 / embryo implantation dysfunction / ovarian stimulation

References

[1] FerrarettiAP, GoossensV, de MouzonJ, et al.. Assisted reproductive technology in Europe, 2008: results generated from European registers by ESHRE. Hum Reprod, 2012, 27(9): 2571-2584

[2] Zegers-HochschildF, AdamsonGD, de MouzonJ, et al.. International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary of ART terminology, 2009. Fertil steril, 2009, 92(5): 1520-1524

[3] FataJE, HoAT, LecoKJ, et al.. Cellular turnover and extracellular matrix remodeling in female reproductive tissues: functions of metalloproteinases and their inhibitors. Cell Mol Life Sci, 2000, 57(1): 77-95

[4] LecoKJ, EdwardsDR, SchultzGA, et al.. Tissue inhibitor of metalloproteinases-3 is the major metalloproteinase inhibitor in the decidualizing murine uterus. Mol reprod Dev, 1996, 45(4): 458-465

[5] FettJW, StrydomDJ, LobbRR, et al.. Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry, 1985, 24(20): 5480-5486

[6] KogaK, OsugaY, TsutsumiO, et al.. Demonstration of angiogenin in human endometrium and its enhanced expression in endometrial tissues in the secretory phase and the decidua. J Clin Endocrinol Metab, 2001, 86(11): 5609-5614

[7] YanushpolskyE, HurwitzS, GreenbergL, et al.. Comparison of Crinone 8% intravaginal gel and intramuscular progesterone supplementation for IVF-ET in women under age 40: interim analysis of a prospective randomized trial. Fertil Steril, 2008, 89(2): 485-487

[8] ChangEM, HanJE, KimYS, et al.. Use of the natural cycle and vitrification thawed blastocyst transfer results in better in-vitro fertilization outcomes: Cycle regimens of vitrification thawed blastocyst transfer. J Assist Reprod Genet, 2011, 28(4): 369-374

[9] GotoS, KadowakiT, HashimotoH, et al.. Stimulation of endometrium embryo transfer can improve implantation and pregnancy rates for patients undergoing assisted reproductive technology for the first time with a high-grade blastocyst. Fertil Steril, 2009, 92(4): 1264-1268

[10] YanJ, LuoJM, WuYX, et al.. The effect on implantation of ovarian stimulation and the improving of Chinese herb. Med J Wuhan Univ (Chinese), 2012, 33(1): 89-92

[11] WuYX, ZhengCH, HuLL, et al.. Local immune regulatory effects of Bangdeyun on the endometrium of mice with embryo implantation dysfunction during the implantation time. J Huazhong Univ Sci Technol [Med Sci], 2009, 29(3): 372-376

[12] DengSR, XuJ, WuYX, et al.. Ovarian stimulation leads to a severe implantation dysfunction. Reprod Biomed Online, 2013

[13] GotoT, EndoT, HenmiH, et al.. Gonadotropin-releasing hormone agonist has the ability to induce increased matrix metalloproteinase (MMP)-2 and membrane type 1-MMP expression in corpora lutea, and structural luteolysis in rats. J Endocrinol, 1999, 161(3): 393-402

[14] ArenaS, MinutoliL, ArenaF, et al.. Polydeoxyribo- nucleotide administration improves the intra-testicular vascularization in ratexperimental varicocele. Fertil Steril, 2012, 97(1): 165-168

[15] KuSY, ChoiYM, SuhCS, et al.. Effect of superovulation on the expression of tissue inhibitor of metalloproteinase-3 in the murine endometrium. Gynecol Obstet Invest, 2003, 55(1): 1-6

[16] ScottiL, IrustaG, AbramovichD, et al.. Administration of agonadotropin-releasing hormone agonist affects corpus luteum vascularstability and development and induces lutea lapoptosis in a rat model of ovarian hyperstimulation syndrome. Mol Cell Endocrinol, 2011, 335(2): 116-125

[17] FanchinR, PeltierE, FrydmanR, et al.. Human chorionic gonadotropin: does it affect human endometrial morphology in vivo. Semin Reprod Med, 2001, 19(1): 31-35

[18] SimonC, Garcia VelascoJJ, ValbuenaD, et al.. Increasing uterine receptivity by decreasing estradiol levels during the preimplantation period in high responders with the use of a follicle-stimulating hormone step-down regimen. Fertil Steril, 1998, 70(2): 234-239

[19] ArtiniPG, FascianiA, MontiM, et al.. Changes in vascular endothelial growth factor levels and the risk of ovarian hyperstimulation syndrome in women enrolled in a vitro fertilization program. Fertil Steril, 1998, 70(3): 560-564

[20] DengSR, XuJ, WuYX, et al.. Determination of flavonoids, saponins and polysaccharides in CYHJ by ultraviolet spectrophotometry. Zhongguo Yiyuan Yaoxue Zazhi (Chinese), 2012, 32(14): 1151-1152

[21] DengSR, ZengJW, WuYX, et al.. Study on the quality standard for Cuyun mixture. Zhongguo Shiyan Fangjixue Zazhi (Chinese), 2012, 18(23): 64-66

[22] YuN, YangJ, YinTL. Extracts from a traditional Chinese herbal remedy (Zhuyun recipe) improve endometrial receptivity in mice with embryonic implantation dysfunction and ovulation stimulation. J Ethnopharmacol, 2011, 137(1): 389-395

[23] AlexanderCM, HansellEJ, BehrendtsenO, et al.. Expression and function of matrix metalloproteinases and their inhibitors at the maternal-embryonic boundary during mouse embryo implantation. Development, 1996, 122(6): 1723-1736

[24] RechtmanMP, ZhangJ, SalamonsenLA. Effect of inhibition of matrix metalloproteinases on endometrial decidualization and implantation in mated rats. J Reprod Fertil, 1999, 117(1): 169-177

[25] ChenL, BeltonRJJr, NowakRA. Basigin-mediated gene expression changes in mouse uterine stromal cells during implantation. Endocrinology, 2009, 150(2): 966-976

[26] LesseyBA, ArnoldJT. Paracrine signaling in the endo metrium: Integrins and the establishment of uterine receptivity. J Reprod Immunol, 1998, 39(1–2): 105-116

[27] KlauberN, RohanRM, FlynnE, et al.. Critical components of the female reproductive pathway are suppressed by the angiogenesis inhibitor AGM-1470. Nat Med, 1997, 3(4): 443-446

[28] RogersPA, DonoghueJF, GirlingJE. Endometrial lymphangiogenesis. Placenta, 2008, 29S: 48-54

[29] StrydomDJ. The angiogenins. Cell Mol Life Sci, 1998, 54(8): 811-824

[30] PavlovN, HatziE, BassagliaY, et al.. Angiogenin distribution in human term placenta and expression by cultured trophoblastic cells. Angiogenesis, 2003, 6(4): 317-330